Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity

1. García-Muñoz, R.
2. López-Díaz-de-Cerio, A.
3. Feliu, J.
4. Panizo, A.
5. Giraldo, P.
6. Rodríguez-Calvillo, M.
7. Grande, C.
8. Pena, E.
9. Olave, M.
10. Panizo, C.
11. Inogés, S.